Healthcare Reimbursement Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
The payment that hospitals, diagnostic centers, doctors, and other health care professionals receive for providing medical services to individuals is known as healthcare reimbursement. Frequently, a government payer or health insurer pays for a person's medical bills in part or in full. The person might claim reimbursement money from the health insurance provider depending on the health insurance plan opted. Payment is typically made after receiving medical services, which is why it is referred to as reimbursement. Advancement in the of electronic medical record (EMR) technology for monitoring patient responsiveness, provider practice, and functioning of health care organizations have the capacity to not only strengthen the accuracy and efficiency of reimbursement policies but also to improve the standard of medical care.
MARKET SCOPE
The "Global Healthcare Reimbursement Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the healthcare reimbursement market with detailed market segmentation by claim, payers and service provider. The report provides key statistics on the market status of the leading healthcare reimbursement market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on claim the market is segmented as, underpaid and full paid.
- Based on payers the market is segmenetd as, provate payers and public payers.
- Based on service provider the market is segmenetd as, physician office, hospitals, diagnostic laboratories and others.
MARKET DYNAMICS
Drivers:
- Growing prevalence of chronic diseases and prolonged hospital stays which ultimately puts a burden of expenses on patients is the key driver for the market growth.
- Rising demand for reimbursement polices which covers all the medical expense of entire family.
- Increasing healthcare expenditures and improvements in healthcare facilities.
Restraints:
- However, issues such as poor quality of care provided to patients, fraudulant activities associated with reimbursement policies are likely to restrain market growth.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The healthcare reimbursement market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the healthcare reimbursement market in these regions.
IMPACT OF COVID-19ON HEALTHCARE REIMBURSEMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The healthcare reimbursement market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the healthcare reimbursement market in these regions.
IMPACT OF COVID-19ON HEALTHCARE REIMBURSEMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the healthcare reimbursement market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from healthcare reimbursement market are anticipated to lucrative growth opportunities in the future with the rising demand for healthcare reimbursement in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the healthcare reimbursement market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- UnitedHealthcare
- Aviva
- Aetna Inc.
- Care Health Insurance
- WellCare Health Plans, Inc.
- AgileHealthInsurance
- Blue Cross and Blue Shield of North Carolina
- Allianz Care
- Max Bupa Health Insurance Company Ltd
- Reliance Nippon Life Insurance Company Limited
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Healthcare Reimbursement Market - By Claim
1.3.2 Healthcare Reimbursement Market - By Payers
1.3.3 Healthcare Reimbursement Market - By Service Provider
1.3.4 Healthcare Reimbursement Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEALTHCARE REIMBURSEMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. HEALTHCARE REIMBURSEMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEALTHCARE REIMBURSEMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. HEALTHCARE REIMBURSEMENT - GLOBAL MARKET OVERVIEW
6.2. HEALTHCARE REIMBURSEMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HEALTHCARE REIMBURSEMENT MARKET - REVENUE AND FORECASTS TO 2028 - CLAIM
7.1. OVERVIEW
7.2. CLAIM MARKET FORECASTS AND ANALYSIS
7.3. UNDERPAID
7.3.1. Overview
7.3.2. Underpaid Market Forecast and Analysis
7.4. FULL PAID
7.4.1. Overview
7.4.2. Full Paid Market Forecast and Analysis
8. HEALTHCARE REIMBURSEMENT MARKET - REVENUE AND FORECASTS TO 2028 - PAYERS
8.1. OVERVIEW
8.2. PAYERS MARKET FORECASTS AND ANALYSIS
8.3. PRIVATE PAYERS
8.3.1. Overview
8.3.2. Private Payers Market Forecast and Analysis
8.4. PUBLIC PAYERS
8.4.1. Overview
8.4.2. Public Payers Market Forecast and Analysis
9. HEALTHCARE REIMBURSEMENT MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE PROVIDER
9.1. OVERVIEW
9.2. SERVICE PROVIDER MARKET FORECASTS AND ANALYSIS
9.3. PHYSICIAN OFFICE
9.3.1. Overview
9.3.2. Physician office Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. DIAGNOSTIC LABORATORIES
9.5.1. Overview
9.5.2. Diagnostic Laboratories Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. HEALTHCARE REIMBURSEMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Healthcare Reimbursement Market Overview
10.1.2 North America Healthcare Reimbursement Market Forecasts and Analysis
10.1.3 North America Healthcare Reimbursement Market Forecasts and Analysis - By Claim
10.1.4 North America Healthcare Reimbursement Market Forecasts and Analysis - By Payers
10.1.5 North America Healthcare Reimbursement Market Forecasts and Analysis - By Service Provider
10.1.6 North America Healthcare Reimbursement Market Forecasts and Analysis - By Countries
10.1.6.1 United States Healthcare Reimbursement Market
10.1.6.1.1 United States Healthcare Reimbursement Market by Claim
10.1.6.1.2 United States Healthcare Reimbursement Market by Payers
10.1.6.1.3 United States Healthcare Reimbursement Market by Service Provider
10.1.6.2 Canada Healthcare Reimbursement Market
10.1.6.2.1 Canada Healthcare Reimbursement Market by Claim
10.1.6.2.2 Canada Healthcare Reimbursement Market by Payers
10.1.6.2.3 Canada Healthcare Reimbursement Market by Service Provider
10.1.6.3 Mexico Healthcare Reimbursement Market
10.1.6.3.1 Mexico Healthcare Reimbursement Market by Claim
10.1.6.3.2 Mexico Healthcare Reimbursement Market by Payers
10.1.6.3.3 Mexico Healthcare Reimbursement Market by Service Provider
10.2. EUROPE
10.2.1 Europe Healthcare Reimbursement Market Overview
10.2.2 Europe Healthcare Reimbursement Market Forecasts and Analysis
10.2.3 Europe Healthcare Reimbursement Market Forecasts and Analysis - By Claim
10.2.4 Europe Healthcare Reimbursement Market Forecasts and Analysis - By Payers
10.2.5 Europe Healthcare Reimbursement Market Forecasts and Analysis - By Service Provider
10.2.6 Europe Healthcare Reimbursement Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Healthcare Reimbursement Market
10.2.6.1.1 Germany Healthcare Reimbursement Market by Claim
10.2.6.1.2 Germany Healthcare Reimbursement Market by Payers
10.2.6.1.3 Germany Healthcare Reimbursement Market by Service Provider
10.2.6.2 France Healthcare Reimbursement Market
10.2.6.2.1 France Healthcare Reimbursement Market by Claim
10.2.6.2.2 France Healthcare Reimbursement Market by Payers
10.2.6.2.3 France Healthcare Reimbursement Market by Service Provider
10.2.6.3 Italy Healthcare Reimbursement Market
10.2.6.3.1 Italy Healthcare Reimbursement Market by Claim
10.2.6.3.2 Italy Healthcare Reimbursement Market by Payers
10.2.6.3.3 Italy Healthcare Reimbursement Market by Service Provider
10.2.6.4 Spain Healthcare Reimbursement Market
10.2.6.4.1 Spain Healthcare Reimbursement Market by Claim
10.2.6.4.2 Spain Healthcare Reimbursement Market by Payers
10.2.6.4.3 Spain Healthcare Reimbursement Market by Service Provider
10.2.6.5 United Kingdom Healthcare Reimbursement Market
10.2.6.5.1 United Kingdom Healthcare Reimbursement Market by Claim
10.2.6.5.2 United Kingdom Healthcare Reimbursement Market by Payers
10.2.6.5.3 United Kingdom Healthcare Reimbursement Market by Service Provider
10.2.6.6 Rest of Europe Healthcare Reimbursement Market
10.2.6.6.1 Rest of Europe Healthcare Reimbursement Market by Claim
10.2.6.6.2 Rest of Europe Healthcare Reimbursement Market by Payers
10.2.6.6.3 Rest of Europe Healthcare Reimbursement Market by Service Provider
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Healthcare Reimbursement Market Overview
10.3.2 Asia-Pacific Healthcare Reimbursement Market Forecasts and Analysis
10.3.3 Asia-Pacific Healthcare Reimbursement Market Forecasts and Analysis - By Claim
10.3.4 Asia-Pacific Healthcare Reimbursement Market Forecasts and Analysis - By Payers
10.3.5 Asia-Pacific Healthcare Reimbursement Market Forecasts and Analysis - By Service Provider
10.3.6 Asia-Pacific Healthcare Reimbursement Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Healthcare Reimbursement Market
10.3.6.1.1 Australia Healthcare Reimbursement Market by Claim
10.3.6.1.2 Australia Healthcare Reimbursement Market by Payers
10.3.6.1.3 Australia Healthcare Reimbursement Market by Service Provider
10.3.6.2 China Healthcare Reimbursement Market
10.3.6.2.1 China Healthcare Reimbursement Market by Claim
10.3.6.2.2 China Healthcare Reimbursement Market by Payers
10.3.6.2.3 China Healthcare Reimbursement Market by Service Provider
10.3.6.3 India Healthcare Reimbursement Market
10.3.6.3.1 India Healthcare Reimbursement Market by Claim
10.3.6.3.2 India Healthcare Reimbursement Market by Payers
10.3.6.3.3 India Healthcare Reimbursement Market by Service Provider
10.3.6.4 Japan Healthcare Reimbursement Market
10.3.6.4.1 Japan Healthcare Reimbursement Market by Claim
10.3.6.4.2 Japan Healthcare Reimbursement Market by Payers
10.3.6.4.3 Japan Healthcare Reimbursement Market by Service Provider
10.3.6.5 South Korea Healthcare Reimbursement Market
10.3.6.5.1 South Korea Healthcare Reimbursement Market by Claim
10.3.6.5.2 South Korea Healthcare Reimbursement Market by Payers
10.3.6.5.3 South Korea Healthcare Reimbursement Market by Service Provider
10.3.6.6 Rest of Asia-Pacific Healthcare Reimbursement Market
10.3.6.6.1 Rest of Asia-Pacific Healthcare Reimbursement Market by Claim
10.3.6.6.2 Rest of Asia-Pacific Healthcare Reimbursement Market by Payers
10.3.6.6.3 Rest of Asia-Pacific Healthcare Reimbursement Market by Service Provider
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Healthcare Reimbursement Market Overview
10.4.2 Middle East and Africa Healthcare Reimbursement Market Forecasts and Analysis
10.4.3 Middle East and Africa Healthcare Reimbursement Market Forecasts and Analysis - By Claim
10.4.4 Middle East and Africa Healthcare Reimbursement Market Forecasts and Analysis - By Payers
10.4.5 Middle East and Africa Healthcare Reimbursement Market Forecasts and Analysis - By Service Provider
10.4.6 Middle East and Africa Healthcare Reimbursement Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Healthcare Reimbursement Market
10.4.6.1.1 South Africa Healthcare Reimbursement Market by Claim
10.4.6.1.2 South Africa Healthcare Reimbursement Market by Payers
10.4.6.1.3 South Africa Healthcare Reimbursement Market by Service Provider
10.4.6.2 Saudi Arabia Healthcare Reimbursement Market
10.4.6.2.1 Saudi Arabia Healthcare Reimbursement Market by Claim
10.4.6.2.2 Saudi Arabia Healthcare Reimbursement Market by Payers
10.4.6.2.3 Saudi Arabia Healthcare Reimbursement Market by Service Provider
10.4.6.3 U.A.E Healthcare Reimbursement Market
10.4.6.3.1 U.A.E Healthcare Reimbursement Market by Claim
10.4.6.3.2 U.A.E Healthcare Reimbursement Market by Payers
10.4.6.3.3 U.A.E Healthcare Reimbursement Market by Service Provider
10.4.6.4 Rest of Middle East and Africa Healthcare Reimbursement Market
10.4.6.4.1 Rest of Middle East and Africa Healthcare Reimbursement Market by Claim
10.4.6.4.2 Rest of Middle East and Africa Healthcare Reimbursement Market by Payers
10.4.6.4.3 Rest of Middle East and Africa Healthcare Reimbursement Market by Service Provider
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Healthcare Reimbursement Market Overview
10.5.2 South and Central America Healthcare Reimbursement Market Forecasts and Analysis
10.5.3 South and Central America Healthcare Reimbursement Market Forecasts and Analysis - By Claim
10.5.4 South and Central America Healthcare Reimbursement Market Forecasts and Analysis - By Payers
10.5.5 South and Central America Healthcare Reimbursement Market Forecasts and Analysis - By Service Provider
10.5.6 South and Central America Healthcare Reimbursement Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Healthcare Reimbursement Market
10.5.6.1.1 Brazil Healthcare Reimbursement Market by Claim
10.5.6.1.2 Brazil Healthcare Reimbursement Market by Payers
10.5.6.1.3 Brazil Healthcare Reimbursement Market by Service Provider
10.5.6.2 Argentina Healthcare Reimbursement Market
10.5.6.2.1 Argentina Healthcare Reimbursement Market by Claim
10.5.6.2.2 Argentina Healthcare Reimbursement Market by Payers
10.5.6.2.3 Argentina Healthcare Reimbursement Market by Service Provider
10.5.6.3 Rest of South and Central America Healthcare Reimbursement Market
10.5.6.3.1 Rest of South and Central America Healthcare Reimbursement Market by Claim
10.5.6.3.2 Rest of South and Central America Healthcare Reimbursement Market by Payers
10.5.6.3.3 Rest of South and Central America Healthcare Reimbursement Market by Service Provider
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HEALTHCARE REIMBURSEMENT MARKET, KEY COMPANY PROFILES
12.1. UNITEDHEALTHCARE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AVIVA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AETNA INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CARE HEALTH INSURANCE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. WELLCARE HEALTH PLANS, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AGILEHEALTHINSURANCE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BLUE CROSS AND BLUE SHIELD OF NORTH CAROLINA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ALLIANZ CARE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MAX BUPA HEALTH INSURANCE COMPANY LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. RELIANCE NIPPON LIFE INSURANCE COMPANY LIMITED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. UnitedHealthcare
2. Aviva
3. Aetna Inc.
4. Care Health Insurance
5. WellCare Health Plans, Inc.
6. AgileHealthInsurance
7. Blue Cross and Blue Shield of North Carolina
8. Allianz Care
9. Max Bupa Health Insurance Company Ltd
10. Reliance Nippon Life Insurance Company Limited
11. BNP Paribas
12. Centene Corporation
13. Medica
14. Life Insurance Corporation of India
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For